INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 195 filers reported holding INSMED INC in Q2 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,680,968 | +19.7% | 66,573 | 0.0% | 0.11% | +113.7% |
| Q2 2023 | $1,404,690 | +23.8% | 66,573 | 0.0% | 0.05% | +96.2% |
| Q1 2023 | $1,135,070 | -34.4% | 66,573 | -23.1% | 0.03% | -13.3% |
| Q4 2022 | $1,730,308 | +167.0% | 86,602 | +187.9% | 0.03% | +172.7% |
| Q3 2022 | $648,000 | -58.2% | 30,085 | -54.4% | 0.01% | -63.3% |
| Q1 2022 | $1,550,000 | +68.5% | 65,971 | +95.3% | 0.03% | +25.0% |
| Q4 2021 | $920,000 | -6.2% | 33,786 | -5.2% | 0.02% | +33.3% |
| Q3 2021 | $981,000 | +10.0% | 35,629 | +13.6% | 0.02% | +12.5% |
| Q2 2021 | $892,000 | -13.6% | 31,358 | +3.4% | 0.02% | -11.1% |
| Q1 2021 | $1,033,000 | +64.2% | 30,320 | +60.4% | 0.02% | +63.6% |
| Q4 2020 | $629,000 | +3.6% | 18,900 | 0.0% | 0.01% | -38.9% |
| Q3 2020 | $607,000 | +23.9% | 18,900 | +6.2% | 0.02% | -21.7% |
| Q2 2020 | $490,000 | – | 17,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 1,056,797 | $33,965,000 | 14.39% |
| Palo Alto Investors LP | 6,032,956 | $193,899,000 | 10.64% |
| Sycale Advisors (NY) LLC | 360,829 | $11,597,000 | 9.99% |
| Burrage Capital Management LLC | 165,400 | $5,316,000 | 4.20% |
| First Light Asset Management, LLC | 1,025,341 | $32,954,000 | 3.38% |
| Rubric Capital Management LP | 1,100,000 | $35,354,000 | 3.30% |
| Sofinnova Investments, Inc. | 615,143 | $19,771,000 | 1.47% |
| Endurant Capital Management LP | 144,313 | $4,638,000 | 1.37% |
| Parkwood LLC | 70,235 | $5,514,000 | 0.85% |
| Novo Holdings A/S | 430,107 | $13,824,000 | 0.69% |